Maximising Your mRNA Characterisation to Ensure Safety, Efficacy & Quality of mRNA Therapeutics
Time: 12:30 pm
day: Conference Day One
Details:
- Reviewing the instrumentation breakthroughs that have advanced mRNA characterisation, allowing for more accurate analysis and overcoming issues related to sensitisation
- Exploring nuclear pore characterisation and how you can control the difference in formulation and heterogeneity of your nanoparticles once administered in the body
- Exploring the latest advances in secondary structure characterisation and how this can optimise its efficacy and safety
